BD HorizonTM BV421 Mouse Anti-Human CD105 (Endoglin)

Description

Multiparameter flow cytometric analysis of CD105 Endoglin expression on Human peripheral blood leucocyte populations. Human whole blood was stained with either BD Horizon BV421 Mouse IgG1, kappa Isotype Control Cat. No. 562438; Left Plot or BD Horizon BV421 Mouse Anti-Human CD105 Endoglin antibody Cat. No. 569032/569033; Right Plot . Erythrocytes were lysed with BD FACS Lysing Solution Cat. No. 349202 . The bivariate pseudocolor density plot showing the correlated expression of CD105 Endoglin or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of intact leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessaX-20 Cell Analyzer System and FlowJo software. Flow cytometric analysis of CD105 Endoglin expression on Human U-937 cells. Cells from the Human U-937 Histiocytic lymphoma, ATCC CRL-1593.2 cell line were stained with either BD Horizon BV421 Mouse IgG1, k Isotype Control Cat. No. 562438; dashed line histogram or BD Horizon BV421 Mouse Anti-Human CD105 Endoglin antibody Cat. No. 569032/569033; solid line histogram . BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells right before analysis. The fluorescence histogram showing CD105 Endoglin expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessaX-20 Cell Analyzer System and FlowJo software. Multiparameter flow cytometric analysis of CD105 Endoglin expression on Human peripheral blood leucocyte populations. Human whole blood was stained with either BD Horizon BV421 Mouse IgG1, kappa Isotype Control Cat. No. 562438; Left Plot or BD Horizon BV421 Mouse Anti-Human CD105 Endoglin antibody Cat. No. 569032/569033; Right Plot . Erythrocytes were lysed with BD FACS Lysing Solution Cat. No. 349202 . The bivariate pseudocolor density plot showing the correlated expression of CD105 Endoglin or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of intact leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessaX-20 Cell Analyzer System and FlowJo software. Show More Flow cytometric analysis of CD105 Endoglin expression on Human U-937 cells. Cells from the Human U-937 Histiocytic lymphoma, ATCC CRL-1593.2 cell line were stained with either BD Horizon BV421 Mouse IgG1, k Isotype Control Cat. No. 562438; dashed line histogram or BD Horizon BV421 Mouse Anti-Human CD105 Endoglin antibody Cat. No. 569032/569033; solid line histogram . BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells right before analysis. The fluorescence histogram showing CD105 Endoglin expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessaX-20 Cell Analyzer System and FlowJo software. Show More Multiparameter flow cytometric analysis of CD105 Endoglin expression on Human peripheral blood leucocyte populations. Human whole blood was stained with either BD Horizon BV421 Mouse IgG1, kappa Isotype Control Cat. No. 562438; Left Plot or BD Horizon BV421 Mouse Anti-Human CD105 Endoglin antibody Cat. No. 569032/569033; Right Plot . Erythrocytes were lysed with BD FACS Lysing Solution Cat. No. 349202 . The bivariate pseudocolor density plot showing the correlated expression of CD105 Endoglin or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of intact leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessaX-20 Cell Analyzer System and FlowJo software. Flow cytometric analysis of CD105 Endoglin expression on Human U-937 cells. Cells from the Human U-937 Histiocytic lymphoma, ATCC CRL-1593.2 cell line were stained with either BD Horizon BV421 Mouse IgG1, k Isotype Control Cat. No. 562438; dashed line histogram or BD Horizon BV421 Mouse Anti-Human CD105 Endoglin antibody Cat. No. 569032/569033; solid line histogram . BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells right before analysis. The fluorescence histogram showing CD105 Endoglin expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD-negative cells. Flow cytometry and data analysis were performed using a BD LSRFortessaX-20 Cell Analyzer System and FlowJo software.